A detailed history of Bryn Mawr Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 59,453 shares of AMGN stock, worth $19.2 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
59,453
Previous 60,190 1.22%
Holding current value
$19.2 Million
Previous $17.1 Million 8.55%
% of portfolio
0.73%
Previous 0.67%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $193,646 - $235,331
-737 Reduced 1.22%
59,453 $18.6 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $387,710 - $468,015
-1,442 Reduced 2.34%
60,190 $17.1 Million
Q3 2023

Nov 15, 2023

SELL
$218.65 - $271.46 $14,430 - $17,916
-66 Reduced 0.11%
61,632 $16.6 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $121,705 - $143,914
568 Added 0.93%
61,698 $13.7 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $86,703 - $105,676
384 Added 0.63%
61,130 $14.8 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $121,843 - $154,817
-532 Reduced 0.87%
60,746 $16 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $637,690 - $719,199
-2,841 Reduced 4.43%
61,278 $13.8 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $648,756 - $721,952
-2,812 Reduced 4.2%
64,119 $15.6 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $1.31 Million - $1.45 Million
-5,992 Reduced 8.22%
66,931 $16.2 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $198,880 - $227,600
-1,000 Reduced 1.35%
72,923 $16.4 Million
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $206,750 - $242,233
-974 Reduced 1.3%
73,923 $15.7 Million
Q2 2021

Jul 29, 2021

SELL
$233.58 - $259.14 $70,307 - $78,001
-301 Reduced 0.4%
74,897 $18.3 Million
Q1 2021

Apr 23, 2021

SELL
$221.91 - $258.6 $780,679 - $909,754
-3,518 Reduced 4.47%
75,198 $18.7 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $315,049 - $375,167
-1,456 Reduced 1.82%
78,716 $18.1 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $750,880 - $835,040
-3,200 Reduced 3.84%
80,172 $20.4 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $2.49 Million - $3.05 Million
-12,575 Reduced 13.11%
83,372 $19.7 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $831,743 - $1.1 Million
4,564 Added 4.99%
95,947 $19.5 Million
Q4 2019

Feb 11, 2020

SELL
$189.21 - $243.2 $263,569 - $338,777
-1,393 Reduced 1.5%
91,383 $22 Million
Q3 2019

Oct 24, 2019

SELL
$174.11 - $208.62 $39,522 - $47,356
-227 Reduced 0.24%
92,776 $18 Million
Q2 2019

Aug 15, 2019

BUY
$166.7 - $195.41 $121,190 - $142,063
727 Added 0.79%
93,003 $17.1 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $199,318 - $224,675
1,102 Added 1.21%
92,276 $17.5 Million
Q4 2018

Aug 28, 2019

BUY
$178.4 - $208.25 $124,880 - $145,775
700 Added 0.77%
91,174 $17.7 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $4.29 Million - $5.01 Million
24,034 Added 36.17%
90,474 $17.6 Million
Q3 2018

Aug 28, 2019

BUY
$185.29 - $208.89 $129,703 - $146,223
700 Added 1.06%
66,440 $13.8 Million
Q3 2018

Nov 15, 2018

SELL
$185.29 - $208.89 $183,251 - $206,592
-989 Reduced 1.48%
65,740 $13.6 Million
Q2 2018

Aug 28, 2019

BUY
$166.05 - $186.51 $116,235 - $130,557
700 Added 1.06%
66,729 $12.3 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $100,792 - $113,211
607 Added 0.93%
66,029 $12.2 Million
Q1 2018

Aug 28, 2019

BUY
$169.43 - $198.0 $118,601 - $138,600
700 Added 1.08%
65,422 $11.2 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $291,080 - $340,164
-1,718 Reduced 2.59%
64,722 $11 Million
Q4 2017

Aug 28, 2019

BUY
$168.79 - $188.59 $113,764 - $127,109
674 Added 1.02%
66,440 $11.6 Million
Q4 2017

Feb 15, 2018

SELL
$168.79 - $188.59 $203,729 - $227,628
-1,207 Reduced 1.8%
65,766 $11.4 Million
Q3 2017

Aug 28, 2019

SELL
$167.29 - $191.0 $396,477 - $452,670
-2,370 Reduced 3.42%
66,973 $12.5 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $11.6 Million - $13.2 Million
69,343
69,343 $12.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.